Kalypso acquired by Rockwell Automation, Inc. (NYSE: ROK). Read the press release.
Big regulatory changes are coming to the way medical device companies sell their products in the European Union (EU). Previous product management strategies are becoming antiquated and exponentially increasing risk.
As a part of the changes in the EU, Unique Device Identification (UDI) and Basic UDI will be a requirement for medical devices. The new regulatory initiative falls under the EU Medical Device Regulation (MDR) and supersedes the Medical Device Directive (MDD), which previously had no provisions on traceability of medical devices, so the steps necessary for compliance are completely new for organizations selling products in the EU market.
As the May 2020 deadline to comply with EU MDR quickly approaches, it's time to take charge of your regulatory compliance strategy and compete to win in the new medical device regulatory climate.
At Kalypso we help companies achieve EU MDR compliance and drive innovation with digitally-enabled products, processes and business models.
We help you build a strong product data backbone with product lifecycle management (PLM); layer in pre-built software accelerators to streamline key processes; and take advantage of key digital technologies like IoT and advanced analytics to tackle key EU MDR initiatives such as:
Our comprehensive EU MDR services are designed to meet you wherever you are in your EU MDR journey:
EU MDR compliance success requires a phased approach to consolidating, connecting and harmonizing cross-functional teams, systems and processes. Our three-phase approach is designed to drive maximum value with an iterative crawl-walk-run cycle.
At Kalypso, our sweet spot is structuring a consolidated PLM system as the product quality and compliance backbone to capitalize on IoT and advanced analytics in support of key EU MDR workstreams:
Kalypso and leading life sciences companies combine the best of both worlds to deliver world-class software implementation and validation support.
Our strategic software partners provide technology solutions to make it easy to accelerate transformation and innovation. They focus exclusively on the regulated biotechnology, pharmaceutical and medical device industries, and are compliance partners with the world’s top technology platforms and applications.